Agreement expands Cardio Diagnostics' global footprint and supports improved detection and management of coronary heart disease in India.
Hosted on MSN
Dr Lal PathLabs reports 16% rise in Q2 profit, declares Rs.7 interim dividend and 1:1 bonus issue
Mumbai, Oct. 31 -- Dr Lal PathLabs Limited reported consolidated revenue of Rs.731 crore for the second quarter of FY2025-26, marking a 10.7% year-on-year increase, while profit after tax (PAT) rose ...
Healthcare services provider Dr Lal PathLabs might be showing up to 50 per cent fall in some trading apps today.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback